SRTA
Strata Critical Medical, Inc.
$5.66
+0.09
(+1.62%)
Mkt Cap
489.74M
Volume
1,355,122
52W Range
3.31-6.02
Sector
Industrials
Beta
2.15
EPS (TTM)
-0.16
P/E Ratio
9.59
Revenue (TTM)
210.22M
Rev Growth (5Y)
+50.0%
EPS Growth (5Y)
N/A
AlphaVal · Fair Value
$11.23
Undervalued · Strong
49.6% below fair value
AlphaQuality · Grade · Gated
F
Stable Earnings Power
38.4 / 100 pillar composite (overridden)
Company Description
Strata Critical Medical, Inc. provides time critical logistics solutions and specialized medical services to healthcare providers across the United States. The company operates as both an air and ground transporter of human organs for transplant. The company was formerly known as Blade Air Mobility, Inc. and change its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 197.14M | 248.69M | 225.18M | 146.12M | 50.53M | 23.43M | 31.20M |
| Net Income | 41.35M | (27.31M) | (56.08M) | (27.26M) | (40.05M) | (10.16M) | (10.84M) |
| EPS | 0.50 | -0.35 | -0.76 | -0.38 | -0.57 | -0.81 | -1.47 |
| Free Cash Flow | (59.92M) | (35.51M) | (34.46M) | (37.86M) | (16.42M) | (11.20M) | (11.16M) |
| FCF / Share | -0.73 | -0.46 | -0.47 | -0.53 | -0.23 | -0.89 | -1.52 |
| Operating CF | (48.91M) | (2.52M) | (32.35M) | (37.13M) | (15.62M) | (10.82M) | (10.30M) |
| Total Assets | 325.47M | 256.68M | 294.94M | 325.02M | 335.88M | 17.71M | 277.69M |
| Total Debt | 3.31M | 9.32M | 24.52M | 18.33M | 716,000 | 1.89M | 462,732 |
| Cash & Equiv | 30.97M | 18.38M | 27.87M | 41.34M | 2.60M | 12.16M | 1.31M |
| Book Value | 279.07M | 221.94M | 234.30M | 274.49M | 291.37M | 11.08M | 5.00M |
| Return on Equity | 0.15 | -0.12 | -0.24 | -0.10 | -0.14 | -0.92 | -2.17 |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 67.38M | 22.74M | 49.30M | 70.80M | 54.31M | 54.36M | 74.88M | 67.94M | 51.51M | 47.48M | 71.44M | 60.99M |
| Net Income | 2.15M | (8.83M) | 57.42M | (3.74M) | (3.49M) | (9.79M) | (1.95M) | (11.33M) | (4.23M) | (33.94M) | 289,000 | (12.23M) |
| EPS | 0.03 | -0.11 | -0.04 | -0.05 | -0.04 | -0.12 | -0.03 | -0.15 | -0.06 | -0.45 | 0.00 | -0.17 |
| Free Cash Flow | (1.93M) | (10.15M) | (34.97M) | (6.94M) | (7.70M) | (5.03M) | (3.56M) | (9.46M) | (16.71M) | (9.34M) | 1.31M | (8.94M) |
| FCF / Share | -0.02 | -0.12 | -0.42 | -0.09 | -0.10 | -0.06 | -0.05 | -0.12 | -0.22 | -0.13 | 0.02 | -0.12 |
| Operating CF | 3.56M | (8.31M) | (31.84M) | (4.21M) | (4.55M) | 13,000 | 6.36M | 7.44M | (15.59M) | (9.32M) | 2.01M | (8.20M) |
| Total Assets | 327.62M | 325.47M | 335.08M | 257.92M | 250.55M | 256.68M | 282.94M | 280.33M | 282.79M | 294.94M | 317.51M | 320.18M |
| Total Debt | 4.47M | 3.31M | 3.47M | 8.84M | 9.07M | 9.32M | 23.74M | 22.01M | 25.53M | 24.52M | 24.35M | 24.21M |
| Cash & Equiv | 58.72M | 30.97M | 22.75M | 58.75M | 34.83M | 18.38M | 20.03M | 26.31M | 36.76M | 27.87M | 36.81M | 37.35M |
| Book Value | 285.73M | 279.07M | 283.00M | 223.10M | 219.73M | 221.94M | 233.50M | 229.39M | 236.61M | 234.30M | 262.88M | 260.76M |
| Return on Equity | 0.01 | -0.03 | 0.20 | -0.02 | -0.02 | -0.04 | -0.01 | -0.05 | -0.02 | -0.14 | 0.00 | -0.05 |
SRTA News
Strata Critical Medical Announces Expiration of Warrants
Strata Critical Medical, Inc. (SRTA) Q1 2026 Earnings Call Transcript
Strata Critical Medical Announces First Quarter 2026 Results
Strata Acquires Ohio Valley Perfusion Associates
Strata Critical Medical Schedules First Quarter 2026 Earnings Conference Call
Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference
Strata Critical Medical: Significant Upside Potential Backed By Robust EBITDA Growth
Strata Critical Medical, Inc. (SRTA) Q4 2025 Earnings Call Transcript
Strata Critical Medical Announces Fourth Quarter 2025 Results
Strata Critical Medical Schedules Fourth Quarter 2025 Earnings Conference Call